Clinical and glaucoma research


22 Rue Alcide-Jentzer
1205 Geneva

Pr. Thumann
Gabriele Thumann
Head of Division


The clinical and glaucoma research of our department comprises the transfer of therapeutic approaches developed in our laboratories into the clinic and clinical trials for new drugs and innovative surgical procedures, especially focusing on the optimisation of treatment approaches for glaucoma. There are five major objectives:

  • Chirurgical methods to rescue from glaucoma, aiming at reducing side effects associated with chirurgical interventions and decrease recovery time.
  • Monitoring of the intra-ocular pressure during 24h in order to establish personalized glaucoma treatments 
  • Optimisation of laser-based treatment for moderate forms of glaucoma
  • Prevention of postoperative scars as much as possible
  • Optimisation of imaging technics and evaluation of glaucoma

Ongoing clinical studies

“The significance of intravitreal anti-VEGF therapy in the severity and progression of peripheral retinal ischemia in patients with diabetic macular edema and diabetic retinopathy”, CCER 15-254

“The influence of aflibercept (Eylea®) on the tonus of retinal vessels in patients with diabetic retinopathy and macular edema”, CCER 15-231

« Valeur diagnostique des signes cliniques dans les traumatismes orbitaires et corrélation entre le type de traumatisme orbitaire et l'atteinte oculaire », CCER 15-191

« Polymerase Chain Reaction sur humeur aqueuse dans les uvéites – Utilité diagnostique et sécurité », CCER 15-188

« Bimatoprost study (Allergan)”, CCER 15-053

“MS-001 study : post market multicentric evaluation of the aquesys xen implant in moderate primary open angle glaucoma subjects”, CCER 14-033

“Post market study to evaluate safety and effectiveness of the innfocus MicroshuntTM (MIDI Arrow) in patients with primary open angle glaucoma”, CCER 14-101

“Argus II Retinal Implant System Feasibility Study”, CCER 07-011


More information

Last update : 29/01/2019